Clinical Trial Update: The Role of KL-6 in the Clinical Diagnosis of ILD

View source ↗

Summary

This clinical trial update reviews the potential role of KL-6 as a diagnostic biomarker for interstitial lung disease, based on a study conducted at Shanghai Pu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease

Snippet

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China | Conditions: Interstitial Lung Disease | Status: COMPLETED